Target intelligence / Profile preview

Carbohydrate fermentation

Molecular classification
Metabolic pathway, Biological process
01

Overview

Carbohydrate fermentation is a complex metabolic process primarily executed by the anaerobic microbiota within the human large intestine (Macfarlane & Macfarlane, 2003). It involves the breakdown of non-digestible carbohydrates, such as dietary fibers, resistant starches, and unabsorbed sugars, into short-chain fatty acids (SCFAs) like acetate, propionate, and butyrate, as well as gases like hydrogen and carbon dioxide (NIH, 2022). This process is vital for host health, providing energy to colonic epithelial cells and influencing systemic metabolism, appetite regulation, and immune function (StatPearls, 2023). Although it is a biological pathway rather than a single molecular target, it is highly relevant in pharmacology; for instance, alpha-glucosidase inhibitors like acarbose promote colonic fermentation by delaying starch absorption in the small intestine (PubChem, 2024). Conversely, excessive or misplaced fermentation, as seen in small intestinal bacterial overgrowth (SIBO), can lead to significant gastrointestinal distress and malabsorption (Mayo Clinic, 2023). Therapeutic strategies often aim to optimize this process through the use of prebiotics, probiotics, or dietary modifications like the low-FODMAP diet to manage symptoms of irritable bowel syndrome.

Other names
Saccharolytic fermentationAnaerobic carbohydrate metabolismColonic fermentationMicrobial carbohydrate metabolism
02

Mechanism of action

Modulation of substrate availability for microbial metabolism in the large intestine and alteration of gut microbiota composition to favor beneficial fermentative outputs.

03

Biological functions

Energy productionShort-chain fatty acid (SCFA) productionGut microbiome maintenancepH regulation in the colonInhibition of pathogen growth
04

Disease associations

Irritable bowel syndrome (IBS)Small intestinal bacterial overgrowth (SIBO)ObesityType 2 diabetesInflammatory bowel disease (IBD)Colorectal cancer
05

Safety considerations

FlatulenceAbdominal bloatingOsmotic diarrheaAbdominal crampingMalabsorption syndromes
06

Interacting drugs

Acarbose

5 more in the full profile.

07

Biomarkers

Breath hydrogen levelsBreath methane levelsFecal short-chain fatty acids (Acetate, Propionate, Butyrate)Fecal pH

Beyond the preview

Go deeper on Carbohydrate fermentation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carbohydrate fermentation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call